Boundless Bio, Inc. BOLD
Set alert
2.43 USD -0.01 -0.41%
As of Nov 3, 12:15 PM ET
2.42 Day range 2.55
0.961 52-week range 3.16
- YTD
- +102.50%
- 1 year
- +77.37%
- Open
- 2.44
- Prev close
- 2.44
- Mkt cap
- 56.00M
- Vol
- 11.30K
- Avg vol
- 174.56K
- EPS
- -2.85
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.42
- High
- 2.55
- Forward P/E
- -0.70
- Beta
- 0.00
- Short ratio
- 2.01
- Inst. own
- 75.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 6, 2025
- 50-d avg
- 2.91
- 200-d avg
- 5.46
- 1y target
- 14.50
Analyst view
Consensus: buy
Buy
Price target (mean) 14.50 +496.7% upside
Now 2.43
- Target (low)
- 14.00
- Target (mean)
- 14.50
- Target (high)
- 15.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78333 | -0.83 – -0.74 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next quarter | -0.77 | -0.78 – -0.76 | -12.27 | +93.7% | 0 | 0.0% | 3 |
| Current year | -7.46 | -14.61 – -3.86 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next year | -3.39 | -3.62 – -3.18 | -7.46 | +54.6% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Guggenheim | Downgrade | Buy | Neutral |
| Apr 22, 2024 | Leerink Partners | Initiated | — | Outperform |
| Apr 22, 2024 | Guggenheim | Initiated | — | Buy |
| Apr 22, 2024 | Piper Sandler | Initiated | — | Overweight |